{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:16:50Z","timestamp":1792019810134,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.anndiagpath.2011.05.005","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T21:04:08Z","timestamp":1313615048000},"source":"Crossref","is-referenced-by-count":5,"title":["Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas"],"prefix":"10.1016","author":[{"given":"Asmaa Gaber","family":"Abdou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa Hassan","family":"Maraee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Mostafa Mohamed","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada Farag","family":"Elnaidany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"61","key":"10.1016\/j.anndiagpath.2011.05.005_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.146.s61.2.x","article-title":"The epidemiology of skin cancer","volume":"146","author":"Diepgen","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R","article-title":"Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA","volume":"81","author":"Karagas","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0015","series-title":"Malignant skin tumors","first-page":"83","article-title":"Cancer Pathology Regestry (2003-2004): and time trend analysis","author":"Mokhtar","year":"2007"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0020","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jama.294.6.681","article-title":"Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years","volume":"294","author":"Christenson","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0025","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nrm882","article-title":"ERM proteins and Merlin: integrators at the cell cortex","volume":"3","author":"Bretscher","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1040-8428(02)00172-5","article-title":"The role of the CD44\/ezrin complex in cancer metastasis [J]","volume":"46","author":"Martin","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0035","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1091\/mbc.E02-07-0410","article-title":"Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation","volume":"14","author":"Pujuguet","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0040","first-page":"100","article-title":"Ecadherin, laminin and collagen IV expression in the evolution fromdysplasia to oral squamous cell carcinoma [J]","volume":"11","author":"Santos G arc","year":"2006","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0045","first-page":"667","article-title":"Practical points on the microscopic grading of carcinoma","volume":"32","author":"Broder","year":"1932","journal-title":"N Y State J Med"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0050","series-title":"TNM classification of malignant tumor. International union against cancer (UICC)","first-page":"52","year":"2002"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0055","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/modpathol.3800174","article-title":"CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression","volume":"17","author":"Bilalovic","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-4632.2009.04191.x","article-title":"Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma","volume":"49","author":"Park","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0065","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1369\/jhc.5A6881.2006","article-title":"Altered expression of ezrin in esophageal squamous cell carcinoma","volume":"54","author":"Zeng","year":"2006","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0070","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/hed.20435","article-title":"Differential tissue and subcellular expression of ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma","volume":"28","author":"Madan","year":"2006","journal-title":"Head Neck"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1600-0560.1998.tb01727.x","article-title":"Expression of moesin and its associated molecule CD44 in epithelial skin tumors","volume":"25","author":"Ichikawa","year":"1998","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0080","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1158\/1078-0432.CCR-1323-03","article-title":"Clinical significance of cellular distribution of moesin in patients with oral squamous cell carcinoma","volume":"10","author":"Kobayashi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0085","first-page":"1231","article-title":"A highly expressed 81KDa protein in immortalized fibroblast: its proliferative function and identity with ezrin","volume":"13","author":"Kaul","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5732\/cjc.009.10505","article-title":"Expression and clinical significance of ezrin and E-cadherin in esophageal squamous cell carcinoma","volume":"29","author":"Zhai","year":"2010","journal-title":"Chinese J Cancer"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0095","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3748\/wjg.15.2016","article-title":"High level of ezrin expression in colorectal cancer tissues","volume":"15","author":"Wang","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0100","doi-asserted-by":"crossref","first-page":"R365","DOI":"10.1186\/bcr1006","article-title":"The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells","volume":"7","author":"Elliott","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0105","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.urology.2003.09.068","article-title":"Expression of ezrin in prostatic intraepithelial neoplasia","volume":"63","author":"Pang","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0110","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1001\/archsurg.140.12.1184","article-title":"Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma","volume":"140","author":"Yeh","year":"2005","journal-title":"Arch Surg"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0115","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/labinvest.3780174","article-title":"Altered expression of the ERM proteins in lung adenocarcinoma","volume":"80","author":"Tokunou","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0120","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.humpath.2008.04.020","article-title":"Intense Cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer","volume":"39","author":"Elzagheid","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3835(01)00857-6","article-title":"Ezrin, a membrane\u2013cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma","volume":"179","author":"Ohtani","year":"2002","journal-title":"Cancer Lett"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0955-0674(97)80154-8","article-title":"ERM (ezrin\/radixin\/moesin) family from cytoskeleton to signal transduction","volume":"9","author":"Tsukita","year":"1997","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0135","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1038\/modpathol.3800512","article-title":"Basal cell carcinoma: biology, morphology and clinical implications","volume":"2","author":"Crowson","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0140","doi-asserted-by":"crossref","first-page":"792","DOI":"10.5858\/2004-128-792-PBCCOT","article-title":"Primary basal cell carcinoma of the nipple","volume":"128","author":"Gupta","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0145","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1468-3083.2010.03853.x","article-title":"Axillary basal cell carcinoma: additional 25 patients and considerations","volume":"25","author":"Betti","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2133.1992.tb14820.x","article-title":"Basal cell carcinoma in young adults","volume":"127","author":"Cox","year":"1992","journal-title":"Br J Dermato"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0155","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1054\/bjps.1999.3267","article-title":"Aggressive basal cell carcinoma in young patients: fact or fiction?","volume":"53","author":"Milroy","year":"2000","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/jcp.2006.036624","article-title":"Value of ezrin, maspin and nm23-H1 protein expression in predicting outcome of patients with head and neck squamous cell carcinoma treated with radical radiotherapy","volume":"60","author":"Mhawech-Fauceglia","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/modpathol.3800300","article-title":"Ezrin in primary cutaneous melanoma","volume":"18","author":"Ilmonen","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1535-6108(04)00031-5","article-title":"Ezrin. A metastatic determinant?","volume":"5","author":"Curto","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0175","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.molmed.2004.03.001","article-title":"Ezrin, a key component in tumor metastasis","volume":"10","author":"Hunter","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0180","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nm982","article-title":"The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis","volume":"10","author":"Khanna","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.anndiagpath.2011.05.005_bb0185","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0090-8258(03)00262-2","article-title":"Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients","volume":"90","author":"Moilanen","year":"2003","journal-title":"Gynecol Oncol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913411000852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913411000852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:30:45Z","timestamp":1638318645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913411000852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":37,"alternative-id":["S1092913411000852"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2011.05.005","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}